For the quarter ending 2026-03-31.
| Income Statement | 2026-03-31 | 2025-12-31 | ||
|---|---|---|---|---|
| Amortization of intangible assets | 57,344 | 57,344 | ||
| Research and development expenses | 3,176,945 | 4,269,479 | ||
| General and administrative expenses | 2,151,088 | 1,935,482 | ||
| Total operating expenses | 5,385,377 | 6,262,305 | ||
| Loss from operations | -5,385,377 | -6,262,305 | ||
| Interest expense | 5,967 | 5,967 | ||
| Interest income | 121,045 | 198,797 | ||
| Total other income, net | 115,078 | 192,830 | ||
| Net loss | -5,270,299 | -6,069,475 | ||
| Basic EPS | -0.7 | -0.77 | ||
| Diluted EPS | -0.7 | -0.77 | ||
| Basic Average Shares | 7,543,923 | 7,920,795 | ||
| Diluted Average Shares | 7,543,923 | 7,920,795 | ||
BIOVIE INC. (BIVIW)
BIOVIE INC. (BIVIW)